Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:tbo-filgrastim
|
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:L03AA14
|
| gptkbp:drugClass |
colony stimulating factor
|
| gptkbp:form |
pre-filled syringe
single-dose vial |
| https://www.w3.org/2000/01/rdf-schema#label |
Granix
|
| gptkbp:indication |
patients receiving myelosuppressive chemotherapy
reduce duration of neutropenia reduce incidence of febrile neutropenia |
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
bone pain
allergic reactions injection site reactions |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
neutropenia
|
| gptkbp:bfsParent |
gptkb:Neulasta
|
| gptkbp:bfsLayer |
7
|